الأربعاء، 13 فبراير 2013

Week marked by Liga match away to Granada

This week is marked by the Liga match away to Granada at Los Cármenes. The team will train on Wednesday, Thursday and Friday at 11.00 at the Ciutat Esportiva Joan Gamper.

The leaders of the league will close out the week on Saturday at 20.00 with the match in Andalusia. The team will have the day off on Sunday, and start to prepare for the away leg of the Champions League knock out stage away to AC Milan.

Monday, February 11
Day off

Tuesday, February 12
Day off

Wednesday, February 13
11.00 - Training session at the Ciutat Esportiva Joan Gamper (first 15 minutes are open to the press)

Thursday, February 14
11.00 - Training session at the Ciutat Esportiva Joan Gamper

Friday, February 15

11.00 - Training session at the Ciutat Esportiva Joan Gamper

Saturday, February 16

20.00 - Liga match against Granada

Sunday, February 17

Day off

46 new Supporters Clubs make the Club even bigger

The Club’s directors met this Monday, February 11th and one of the items they approved was the incorporation of 46 new penyes.

The Club welcomes the new penyes, who will certainly help Barça continue to be a reference point in the social area around the world.

Below are the names of the new penyes:

Peña Azulgrana de Fuencaliente (Fuencaliente, Ciudad Real)

Penya Blaugrana Nicolau Casaus de Sant Andreu de la Barca (Sant Andreu de la Barca, Barcelona)

Penya Barcelonista Chicho Sibilio (Distrito Federal, Dominican Republic)

Penya Barcelonistas de Gante (Ghent, Belgium)

Asociación Peña Barcelonista de Porriño (O Porriño, Pontevedra)

Peña Barcelonista de Ablitas (Ablitas, Navarra)

Peña Barcelonista Paco Seirul·lo (Salamanca, Salamanca)

Penya Barcelonista de Sineu (Sineu, Balearic Islands)

Penya Blaugrana d'Artesa de Lleida (Artesa de Lleida, Lleida)

Penya Barcelonista Do Barbanza (Boiro, La Coruña)

Peña Barcelonista de Ruecas (Ruecas, Badajoz)

Peña Barcelonista Dilar (Dilar, Granada)

Peña Barcelonista Almadén de la Plata (Almadén de la Plata, Sevilla)

Penya Barcelonista de Monofacio (Tefeli, Crete)

Penya Blaugrana de Llivia (Llivia, Girona)

Penya Blaugrana de Maracay Gent del Barça (Maracay, Venezuela)

Penya Barcelonista de Beneixema (Beneixema, Alicante)

Penya Barcelonista de Campins (Campins, Barcelona)

Peña Castillo Blaugrana (Bercial, Segovia)

Peña Barcelonista de Pedroche (Pedroche, Córdoba)

Penya Blaugrana Aït Nsar (Aït Nsar, Morocco)

Penya Barcelonista di Bergamo - Città dei Mille (Bergamo, Italy)

Peña Barcelonista San Benito (San Benito de la Contienda, Badajoz)

Penya Barcelonista Alcalà-Alcossebre (Alcalà de Xivert, Castelló)

Peña Barcelonista Pasión Culé de Zaragoza (Zaragoza)

Peña Barcelonista de Tauste (Tauste, Zaragoza)

Peña Barcelonista Colloto (Colloto, Asturias)

Penya Blaugrana Gerard Piqué de Talamanca (Talamanaca, Barcelona)

Gent Blaugrana d'Anfa (Casablanca, Morocco)

Penya Barcelonista de Castelldans (Castelldans, Lleida)

Penya Barcelonista de Sils (Sils, Girona)

Peña Barcelonista "El Toboso" (El Toboso, Toledo)

Penya Blaugrana del Conflent (Prades, France)

Penya Barcelonista Ibense "Reyes Magos" (Ibi, Alicante)

Penya Blaugrana Garriguella (Garriguella, Girona)

Barcelona Fan Club Guanzhou (Guanzhou, China)

Penya Barcelonista Vall de Guadalest (Guadalest, Alicante)

Peña Barcelonista Santiago de Calatrava (Santiago de Calatrava, Jaén)

Penya Blaugrana Garraf (Garraf, Barcelona)

Penya Barcelonista Knokke-Heist (Bruges, Belgium)

Peña Barcelonista Nerjeña (Nerja, Málaga)

Bayerische Penya Blaugrana (Munich, Germany)

Penya Blaugrana de Calahonda (Mijas Costa, Málaga)

Penya Blaugrana de Bellaterra (Bellaterra, Barcelona)

Penya Barcelonista Eslovaca dels Altos Tatras (Bratislava, Slovakia)

Peña Barcelonista de Córdoba (Córdoba)

FCB Regal - Valencia Basket: Copa del Rey champions! (85-69)

Barça Regal won the Copa del Rey this Sunday evening, the first big title of the season, after defeating Valencia Basket in the final by 85 to 69. The men managed by Xavi Pascual jumped to an insurmountable lead in the fourth quarter and won the 23rd Cup in Club history.

Equal first half
In a final it’s always important to strike first, this let’s your rival know that you mean business and that you’re on form. This was the attitude that Barça Regal had when they came out onto the Buesa Arena court and in five minutes they already had an eight-point lead (14-6). Víctor Sada led the Blaugrana in the opening minutes - 7 of the team’s 14 points were his - which forced Perasovic to call timeout.

Valencia reacted with a 3-12 run of their own. The teams finished the first quarter with 17 to 18 on the scoreboard. Both sides were evenly matched in the second quarter. Perasovic’s men started knocking down points from beyond the three-point line and jumped to a five-point lead (21-26). That was the biggest lead Valencia enjoyed in the second quarter, but Barça fired back and took a three-point lead thanks to Jawai, Oleson and Wallace (36-33).

Importance difference

At the start of the second half, Barça Regal came out with one idea: break the game. Said and done. An imperious Jawai dominated on both sides of the court and Oleson knocked down four consecutive points. The difference of 52 to 39 seemed to be close to decisive, but Valencia never gives up, and much less in a final. They fought back to come within eight points (61-45) at the end of the third quarter.

Lorbek secures the title

On various occasions Barça could have closed out the game, but they were unable to land the crippling blow. In fact, Valencia came within five points of Barça in the last quarter (63-57), but a 7-0 run led by Oleson and Lorbek saw Barça take a 13-point lead (70-57). In the last four minutes of the game, the Slovenian proved decisive on both sides of the court.

The final score of 85 to 69 secured the third Cup of the Xavi Pascual era and the 23rd Cup in the history of FC Barcelona.

Leo Messi and Andrés Iniesta, face to face

The two players with their respective individual prizes to talk about their origins and the essence of the Masia style

Messi: “The Barça philosophy isn’t about just one coach or another, it’s based on an idea, a line that is laid down and all coaches follow. That has always been the way in which the Club has worked with the academy”

Iniesta: “The Barça way of playing – which we’ve worked on for such a long time –helps create success. The most important thing is to have an idea, but you have to have the right players to put it into practice – the two have to go hand in hand”

Leo Messi and Andrés Iniesta / PHOTO: REVISTA BARÇA.

New 2012 Berlin Definition for ARDS

The new 2012 definition for Acute Respiratory Distress Syndrome (ARDS) (published in JAMA June 2012)


According to the previous definition published in 1994 by the American-European Consensus Conference (AECC), ARDS must have the following 4 criteria:
  • the onset must be acute
  • there must be hypoxemia with PaO2/FIO2 ratio ≤ 200
  • there must be bilateral infiltrates on CXR
  • these findings cannot be attributed to other causes
A separate category for acute lung injury (ALI) is defined with PaO2/FIO2 ≤ 300

However, a number of problems are found with the 1994 definition, including:

  • term 'acute' was not defined (i.e., how "acute" is acute)
  • the category of ratio PaO2/FIO2 between 201-300 is confusing (PaO2/FIO2 ≤ 300 is ALI, PaO2/FIO2  ≤  200 is ARDS, PaO2/FIO2 between 201 - 300 ?ALI/ARDS)
  • CXR interpretation has poor inter-observer reliability

With this, the new Berlin 2012 definition of ARDS is published with the following changes:
  1. the category of acute lung injury (ALI) with PaO2/FIO2 ≤ 300 is REMOVED
  2. instead, ARDS is now divided into three categories based on severity of hypoxemia
    1. PaO2/FIO2 between 200–300 is defined as mild
    2. PaO2/FIO2 between 101 - 199 is defined as moderate
    3. PaO2/FIO2 of less than 100 is defined as severe
  3. The term 'acute' now has a specified time frame of symptoms developing within ONE week of a known clinical insult
  4. Other changes:
    1. the CXR criteria is now more defined with the added phrase "bilateral opacities - not fully explained by effusions, lobar/lung collapse, or nodules"
    2. PCWP reading is no longer required as part of the diagnosis as this is increasingly not used. Instead, this new definition requires that the respiratory failure cannot be explained fully by cardiac failure or volume overload.

Editorial comment in JAMA June 2012 points out that this new definition only improves its predictive value of mortality slightly; however, the clarity of the criteria is significantly improved.

Ref:The ARDS Definition Task Force. Acute respiratory distress syndrome: The Berlin definition. JAMA 2012 Jun 20; 307:2526
Abstract: http://jama.jamanetwork.com/article.aspx?articleid=1160659

A case of recurrent abdominal distension


A 50-year old man with recurrent history of unable to pass stools for 3 days’ duration with abdominal distension. Otherwise he appears comfortable. On examination, abdomen is distended, but soft and non-tender on palpation. Bowel sounds were diminished. He had multiple admissions for similar complaints for the last two years. The abdominal x-ray for the current admission is as below:



And the abdominal x-ray taken 9 months ago when he was admitted similarly is as below:


Further history revealed that when he presented for the first time, the surgical team performed an exploratory laparatomy and found no abnormality. He has history of schizophrenia and is on antipsychotics. 

What diagnosis should you consider in this case?


Ans: recurrent colonic pseudo-obstruction also known as Ogilvie Syndrome.

Pathophysiology:

1. When Ogilvie first described these cases, he hypothesized that the etiology was due to sympathetic deprivation to the colon, leading to unopposed parasympathetic tone, resulting in regional contraction, and thus functional obstruction.

2. However, the current understanding is, unlike the hypothesis Ogilvie proposed, is because of parasympathetic suppression (in this case, sacral parasympathetic outflow), or excessive sympathetic stimulation (Maloney & Vargas, 2005)

RECALL that:
the parasympathetic nervous system increases gut motility and
the sympathetic nervous system decreases gut motility

Thus, in the presence of disruption of the parasympathetic stimulation, results in reduced gut motility or adynamic of distal gut segment, resulting in functional dilatation. This hypothesis is supported by the use of neostigmine in the treatment of this condition.

3. Neostigmine is an acetycholinesterase inhibitor (Ponec et al, 1999).
Acetycholinesterase results in the breakdown of acetylcholine into acetate and choline.
Thus, neostigmine, by inhibiting the action of this acetylcholinesterase, inhibits the breakdown of acetylcholine (by the same token, neostigmine can be used to treat myastenia gravis by increasing the concentration of acetycholine)

4. The cecum is the usual site of the largest dilatation in Ogilvie syndrome and, thus, is more prone to the risk of perforation. This is because cecum has a large diameter. Laplace law states that the intraluminal pressure needed to stretch the wall of a hollow tube is inversely proportional to its diameter.  Thus, because of its large diameter, it is easier to overcome the wall tension of cecum with a small amount of pressure than with other parts of the gut (Click here to access the article in emedicine)

5. Of course, this syndrome has to be a diagnosis of exclusion. Mechanical obstruction has to be ruled out. In this patient, exploratory laparatomy was first performed and the gut was found to be normal.


6. The patient is on anti-psychotic drugs. Many of these anti-psychotics such as phenothiazines have anticholinergic properties; thus aggravate this patient's condition.

Click here for a chapter on Ogilvie Syndrome

One should also differentiate toxic megacolon from Ogilvie syndrome. However, the clinical features in toxic megacolon are quite different from this syndrome. Patient with toxic megacolon is rather sick looking. Jalan criteria for toxic megacolon are:
  • Radiographic evidence of colonic dilatation - The classic finding is more than 6cm in the transverse colon PLUS
  • Any 3 out of 4 of the following
    • Fever (>38.6C)
    • Tachycardia (>120/min)
    • Leukocytosis (>10.5 x 103/µL) or 
    • anemia  PLUS
  • Any 1 of the following - Dehydration, altered mental status, electrolyte abnormality, or hypotension
(Jalan KN, Sircus W, Card WI, Falconer CW, Bruce CB, Crean GP, McManus JP, Small WP, Smith AN. An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroenterology. 1969 Jul;57(1):68-82.)




References:
1. Maloney N, Vargas HD. Acute intestinal pseudo-obstruction (Ogilvie's syndrome). Clin Colon Rectal Surg. 2005 May;18(2):96-101. Click here for free full text in pdf

2. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med. 1999 Jul 15;341(3):137-41. Click here for free full text.

10 things I learned from the 46th Malaysia-Singapore Congress of Medicine



10 things I learned from the 46th Malaysia-Singapore Congress of Medicine

Although this congress has not much relevant topics pertaining to emergency medicine, I learned a number of things on cardiometabolic updates. Below are some of the things I learned:

1. In a patient with STABLE coronary disease, a recent landmark trial called the COURAGE trial shows that the nearly 5-year incidence of death or MI was similar whether the patient undergoes PCI or optimized medical therapy alone, although PCI showed some advantage in relieving angina.

Reference:Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007 Apr 12;356(15):1503-16. Click here to download the FREE FULL TEXT in pdf

2. However, in another on-going study with has to be halted prematurely (the FAME II study), for a specific sub-group of patients with stable coronary disease and documented hemodynamically significant stenosis (detected from fractional flow reserve, FFR), these patients will have a more than 10-times-higher risk of urgent revascularization if they are initially treated with optimal medical therapy (OMT) rather than PCI.

Hence, as the coordinating clinical investigator of this trial, Dr Bernard De Bruyne, said, the findings from FAME II are not "anti-COURAGE", but a complement or an extension of "COURAGE."

In other words, if properly selected, a patient would benefit significantly from PCI.
3. In a patient with left ventricular systolic dysfunction, CABG may reduce the risk for cardiovascular death or revascularization, but it does not appear to prolong life compared with contemporary guideline-based medical therapy (no statistical significant difference in the rate of all-cause mortality in a follow-up of up to nearly 5 years) (STICH trial)

Reference:
Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med.  Apr 28;364(17):1607-16. Click here to download the FREE FULL TEXT in pdf
4.  In a patient with homozygous familial hypercholesterolemia (FH), with very high cholesterol level and who do not respond well to maximum multiple drug therapy, LDL apheresis may be considered (much like renal dialysis). Meanwhile statins have the adverse effect of elevating the liver enzymes.

Reference:
2011 Malaysian CPG Management of Dyslipidemia (4th ed). Click here to download the FREE FULL TEXT in pdf

5.  Statins, especially in high dose, can cause derangement in liver enzymes but ACC/AHA/NHLBI recommends that statins should be discontinued (or lowered the dose of) if the ALT or AST are above 3 times the upper limit of normal on 2 consecutive occasions. Nonetheless, the exact mechanism of how statins cause elevations of ALT and AST is still unknown.

Reference:
Pasternak RC, Smith SC, Jr., Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C. ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. Circulation. 2002 Aug 20;106(8):1024-8. Click here to download the FREE FULL TEXT in pdf
6. For patient with subclinical hypothyroidism, initiate treatment if the TSH ≥10 mIU/L. TSH levels ≥10 mIU/L associated with increased cardiovascular morbidity and mortality.

Reference:
Weiss IA, Bloomgarden N, Frishman WH. Subclinical hypothyroidism and cardiovascular risk: recommendations for treatment. Cardiol Rev.  Nov-Dec;19(6):291-9.

7. Overt hyperthyroidism which has been shown to be associated with cardiac arrhythmias, hypercoagulopathy, stroke, and pulmonary embolism, is found to be associated with a 20% increased mortality in a recent meta-analysis.

Reference:
Brandt F, Green A, Hegedus L, Brix TH. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. Eur J Endocrinol.  Oct;165(4):491-7. Click here to download the FREE FULL TEXT in pdf
8. Metformin is the only oral anti-diabetic that has been proven to reduce cardiovascular mortality in trials such as the UKPDS; and as such, it should be continued unless the patient has been shown to have documented a GFR reduction <30%. Metformin does not cause hypoglycemia attack and has been shown to be weight neutral or result in weight reduction. Lactic acidosis is a concern but only in the presence of hepatic failure. There is, however, a question that metformin may lead to Vit B12 deficiency over a long term use.
Thiazolidinediones, like rosiglitazone, has been shown to be associated with an increased risk for myocardial infarction and possibly cardiovascular mortality in a recent meta-analysis.  There are also evidence to suggest that thiazolidinediones may increase risk of bladder cancer (click here for an article).

References:
1. Management of Type 2 Diabetes 2009 - Malaysian CPG. Click here to download the FREE FULL TEXT in pdf.

2. Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ. Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. N Engl J Med. 2007 Jul 5;357(1):28-38. Click here for full text access.

9. Bariatric surgery is a useful and appropriate treatment for obese people with type 2 diabetes NOT achieving the recommended treatment targets with medical therapies, especially when there are other major co-morbidities.

Diabetic patients with a BMI between 30 and 35 and cannot be adequately controlled by optimal medical regimen and especially in the presence of other major cardiovascular disease risk factors, may also be considered for bariatric surgery.

There are various methods of bariatric surgery, which can be divided into
  • Gastric restrictive procedures (laparoscopic adjustable gastric banding, sleeve gastrectomy, vertical gastroplasty) limit gastric volume and, hence, restrict the intake of calories by inducing satiety. Gastric banding, for example, may limit the volume to only 30 ml or 2 table spoons!
  • Intestinal bypass procedures (Roux-en-Y gastric bypass, biliopancreatic diversion) also restrict caloric intake, the way gastric banding and vertical gastroplasty do. But because the small intestine is shortened, they have an added component of malabsorption of fat and nutrients.
Bariatric surgery as a treatment for Type 2 diabetes is endorsed by the International Diabetes Federation (IDF) in its position statement on bariatric surgery. Click here to download the statement.

However, the  IDF position statement recommends only 2 procedures, namely Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB), are currently conventional bariatric surgical procedures for adolescents.




The image is taken from Cleveland Clinic Journal of Medicine at URL http://www.ccjm.org/content/77/7/468/F1.large.jpg for educational purpose only


How does bariatric surgery works? Besides limiting the volume of the "stomach", bariatric surgery induces a number of hormonal or metabolic changes. There are two theories behind:
  • the “hindgut theory” which suggests that accelerated transit of concentrated nutrients (particularly glucose) to the distal intestine results in increased production of insulinotropic and appetite-controlling substances
  • the “foregut theory” which suggests that since nutrient interactions in the duodenum are diabetogenic; through bypassing the duodenum, this would reverse this defect. 
Reference:
Kashyap SR, Gatmaitan P, Brethauer S, Schauer P. Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med.  Jul;77(7):468-76. Click here to download the FREE FULL TEXT in pdf.
10. Contrary to what many think, an infant's low birth weight and poor nutrition can actually lead to increased prevalence of coronary heart disease, diabetes, hypertension, stroke, etc during adult life.This is known as the Barker hypothesis because it was first described by Barker in an epidemiology study.

Epigenetics is the study of the heritable changes in gene expression or cellular phenotype WITHOUT changes in the underlying DNA sequence – hence the name epi- (over, above, outer) -genetics.

It refers to functionally relevant modifications to the genome by mechanisms such as the histone chain that wraps around the gene. The more tightly "wrapped" the gene is, the more silenced the gene becomes.  The other mechanism is through epigenome tags such as the methyl tag.  The more methylation, the more silenced the gene becomes.

These epigenomes can interact with the environment and can "listen" to signals from the environment. This, early-life metabolic adaptations help in survival of the organism by selecting an appropriate trajectory of growth in response to environmental cues.

Click here to watch a video on epigenetics.

Reference: 
Barker DJ. Fetal origins of coronary heart disease. BMJ. 1995 Jul 15;311(6998):171-4.